Corbus Pharmaceuticals Holdings Inc

NASDAQ:CRBP 4:00:00 PM EDT

6.90

-0.50 (-6.76%)

7:47:27 PM EDT: $7.10 +0.20 (+2.90%)

Corbus Pharmaceuticals Holdings Inc Stock, NASDAQ:CRBP

500 River Ridge Drive, 2nd floor, Norwood, Massachusetts 02062

United States of America

Phone: +1.617.963.0100

Number of Employees: 28

http://www.corbuspharma.com

Description

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFÃ?Å? expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.